ACTIVE

STEANN PHARMA

Export PDF

Financial year 2025 · Closed on 31/03/2025

Net result228,4 k €+91,4 %over 1 year
Gross margin178,2 k €-12,8 %over 1 year
Equity958,8 k €+31,3 %over 1 year

Identity

Source · BCE/KBO

STEANN PHARMA is a Private limited company incorporated in 2016. Its main activity is: Management consultancy activities. Its registered office is in Duffel.

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 0660.893.761
Incorporation
12/08/2016
Legal form
Private limited company
Registered office
Hoogstraat 294 box C
2570 Duffel · FlandreSee on map
Contributed capital
75 000,00 €
Latest accounts
31/03/2025
Signals
ProfitableSolid equityPositive cashflowPositive EBITDA

Financials

Source · NBB, 9 filings

Trend over 8 financial years

20252024202320222021
Income statement
Gross margin178,2 k €204,4 k €195,9 k €173,1 k €203 k €
EBITDA176,5 k €202,9 k €194,8 k €172 k €201,9 k €
Operating result114,5 k €198,3 k €194,8 k €172 k €201,9 k €
Net result228,4 k €119,3 k €122,9 k €108,5 k €132,4 k €
Balance sheet
Equity958,8 k €730,5 k €611,2 k €488,2 k €549,7 k €
Total assets2,1 M €1,5 M €1,6 M €1,3 M €1,3 M €
Cash29,2 k €13,6 k €231,7 k €211 k €192,2 k €
Debts1,1 M €737,3 k €1 M €837,5 k €758,2 k €

Valuation

Indicative valuation

As an indication, this company is worth

between 500 k€ and 1 M€
See the valuation

Board of directors

Source · NBB, accounts to 31/03/2025

1 active · 1 ended

Active mandates

DirectorMandates in this companyPeriodOther mandatescurrentendedstruck offbankruptcies
Anneleen De Swert
DirectorManager12/08/2016 → 2018 accountsended

Ended mandates

DirectorMandates in this companyPeriodOther mandatescurrentendedstruck offbankruptcies
A.N.W. - SOFT0457.440.221Represented by Willem De Swert
Director2022 accounts

Other companies at this address

Hoogstraat 294 2570 Duffel
CompanyCBE no.
Advocatenkantoor Nick Paeleman● Active
0719.581.929
A.N.W. - SOFT● Active
0457.440.221

Full financial information

Source · NBB
202520242023202220212020
Type of accountAbridged modelAbridged modelAbridged modelAbridged modelAbridged modelAbridged model
Start of the financial year01/04/202401/04/202301/04/202201/04/202101/04/202001/04/2019
Closing of the financial year31/03/202531/03/202431/03/202331/03/202231/03/202131/03/2020
Length of the financial year12 months12 months12 months12 months12 months12 months
Filing date25/11/202515/10/202414/11/202328/10/202227/09/202113/10/2020
General meeting19/11/202520/09/202415/09/202330/09/202217/09/202118/09/2020
Currency of the financial yearEUREUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 9 filings
ModelClosingGeneral meetingFiledLanguageDocument
Abridged modelCorrection31/03/202519/11/202525/11/2025DutchPDF
Abridged model31/03/202519/09/202520/10/2025DutchPDF
Abridged model31/03/202420/09/202415/10/2024DutchPDF
Abridged model31/03/202315/09/202314/11/2023DutchPDF
Abridged model31/03/202230/09/202228/10/2022DutchPDF
Abridged model31/03/202117/09/202127/09/2021DutchPDF
Abridged model31/03/202018/09/202013/10/2020DutchPDF
Abridged model31/03/201920/09/201924/09/2019DutchPDF
Abridged model31/03/201821/09/201825/09/2018DutchPDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 500 k€ and 1 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/03/2025

1 active · 1 ended

Active mandates

DirectorMandates in this companyPeriodOther mandatescurrentendedstruck offbankruptcies
Anneleen De Swert
DirectorManager12/08/2016 → 2018 accountsended

Ended mandates

DirectorMandates in this companyPeriodOther mandatescurrentendedstruck offbankruptcies
A.N.W. - SOFT0457.440.221Represented by Willem De Swert
Director2022 accounts

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette
  • Mandates19/01/2024
    WIJZIGING RECHTSVORM - ONTSLAGEN - BENOEMINGEN - KAPITAAL - AANDELEN
    PDF
  • Mandates06/01/2022
    MAATSCHAPPELIJKE ZETEL - ONTSLAGEN - BENOEMINGEN
    PDF
  • Other17/08/2016
    Uit een akte, verleden voor ons, meester Jan Verreth, notaris te Lier, op 10 augustus 2016, blijkt dat
    PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

Source · CBE, NBB annual accounts
Year
Identity
Incorporation
Name
Registered office
Annual accounts
Filings8 filings
Mandates
Anneleen De Swert
A.N.W. - SOFT
20162017201820192020202120222023202420252026
STEANN PHARMA
Hoogstraat 294C, 2570 Duffel
DirectorManager
CurrentPlanned, not yet servedEndedAccounts filedToday

Registered offices

Source · NBB annual accounts, CBE
Registered addressPeriodSource
Hoogstraat 294 bte C, 2570 DuffelCurrent
CBE
Hoogstraat 294C, 2570 Duffel
accounts 2022 → 2025
Accounts 2025 · 2025-00571218

Company names

Source · NBB annual accounts, CBE
NamePeriodSource
STEANN PHARMACurrent
accounts 2022 → 2025
Accounts 2025 · 2025-00571218

Events

  1. 2025
    Annual accounts 2025228,4 k €↑
  2. 2024
    Annual accounts 2024119,3 k €↓
  3. 2023
    Annual accounts 2023122,9 k €↑
  4. 2022
    Annual accounts 2022108,5 k €↓
  5. 2021
    Annual accounts 2021132,4 k €↓
  6. 2020
    Annual accounts 2020135,3 k €↑
  7. 2019
    Annual accounts 2019110,8 k €↑
  8. 2018
    Annual accounts 201896,2 k €
  9. 12/08/2016
    IncorporationPrivate limited company